{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Curexa%20%E2%80%93%20East%2C%20LLC%20dba%20Curexa","name":"Curexa – East, LLC dba Curexa","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-07T13:15:31.890Z"},"count":1,"matches":[{"id":"a77bd291127973c7","posted_date":"2024-01-09","letter_issue_date":"2023-09-13","company_name":"Curexa – East, LLC dba Curexa","issuing_office":"Office of Pharmaceutical Quality","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/a77bd291127973c7"}]}